植物大豆®17.5毫克

Phyto Soya®大豆异黄酮

基于10年的专业经验,Arkopharma医药实验室研制出Phyto Soya®大豆异黄酮,帮助女性缓解更年期不适:这种膳食补充剂的主要成分是受管控的高质量大豆提取物,原料来源于于传统农业,保证非转基因.

13位条形码:3578830132088 - 60粒装
13位条形码:3578830132071 - 180粒装

膳食补充剂.
仅限45岁以上的女性服用.

  • 每天早晚各服用1粒胶囊,随餐用一大杯水送服(250ml).
    如有需要,可将剂量增加至每天4粒胶囊(早晚各2粒).

注意事项

  • 不建议孕妇和哺乳期女性服用.
  • 不建议乳腺癌或有乳腺癌家族遗传史的人群服用.
  • 膳食补充剂不能替代平衡、多样的饮食以及健康的生活方式.
  • 勿超过每日建议用量.
  • 请置于儿童不能触及的地方.
  • 避免高温、阳光照射及潮湿环境.

Albert A, Altabre C, Baro F, Buendia E, Cabero A, Cancelo Mj et al. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology : a multicentric, open, prospective and non-randomized trial. Phytomedicine 2002;9:85-92.

Brzezinski A, Adlercreutz H, Shaoul R, Rosier A, Shmueli A, Tanos V et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4(2):89-94.

Chedraui P, San Miguel G, Schwager G. The effect of soy-derived isoflavones over hot flushes, menopausal symptoms and mood in climacteric women with increased body mass index. Gynecol Endocrinol 2011;27(5):307-13.

Cianci A, Cicero AF, Colacurci N, Matarazzo MG, De Leo V. Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. Gynecol Endocrinol 2012;28(9):699-702.

Crawford SL, Jackson EA, Churchill L, Lampe JW, Leung K, Ockene JK. Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial. Menopause 2013;20(9):936-45.

Franco OH, Chowdhury R, Troup J, Voortman T, Kunutsor S, Kavousi M et al. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. JAMA 2016;315(23):2554-63.

Hirose A, Terauchi M, Akiyoshi M, Owa Y, Kato K, Kubota T. Low-dose isoflavone aglycone alleviates psychological symptoms of menopause in Japanese women: a randomized, double-blind, placebo-controlled study. Arch Gynecol Obstet 2016;293(3):609-15.

Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas 2007;58(3):249-58.

Palacios S, Mares P, Pornel B, Chantre P. Endometrial safety assessment of a specific and standardized soy isoflavones extract (PHYTO SOYA®) in post-menopausal women. Menopause 2006;13(6):1009.

Palacios S, Pornel B, Vázquez F, Aubert L, Chantre P, Marès P. Long-term endometrial and breast safety of a specific, standardized soy extract. Climacteric 2010;13(4):368‑75.

Scambia G, Mango D, Signorile P, Angeli R, Palena C, Gallo D et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7(2):105-11.

Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL et al. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am J Clin Nutr 2011;93(2):356-67.

Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause 2012;19(7):776-90.

Tranche S, Brotons C, Pascual de la Pisa B, Macías R, Hevia E, Marzo-Castillejo M. Impact of a soy drink on climacteric symptoms: an open-label, crossover, randomized clinical trial. Gynecol Endocrinol 2016;32(6):477-82.

Upmalis D, Lobo R, Bradley L, Warren M, Cone F, Lamia C. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicentre, double-blind, randomized, placebo-controlled study. Menopause 2000;7(4):236-42.

Wasburn S, Burke Gl, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6(1):7-13.

成分详情

大豆精粹(Glycine max (L.) Merrill)-补充剂:纤维素-抗凝剂:硬脂酸镁-植物胶囊:羟丙甲.
基纤维素-色素:二氧化钛、氧化铁.


营养成分表 

  2粒胶囊 4粒胶囊
大豆精粹 350 mg 700 mg
  大豆异黄酮含量 35 mg 70 mg
 异黄酮(以糖苷配基表示) 22 mg 44 mg
         

 

 

 

 

Phyto Soya®中含有的大豆提取物经临床证明对乳房和子宫内膜安全*。


*对395名更年期女性进行的临床研究,每天服用70毫克大豆异黄酮,连续服用3年。研究发表于科学杂志Climateric 2010。食品安全由欧洲食品安全局确认:EFSA Journal 2015; 13 (10):4246 [342 pp]。

成分详情

大豆精粹(Glycine max (L.) Merrill)-补充剂:纤维素-抗凝剂:硬脂酸镁-植物胶囊:羟丙甲.
基纤维素-色素:二氧化钛、氧化铁.


营养成分表 

  2粒胶囊 4粒胶囊
大豆精粹 350 mg 700 mg
  大豆异黄酮含量 35 mg 70 mg
 异黄酮(以糖苷配基表示) 22 mg 44 mg
         

 

 

 

 

Phyto Soya®中含有的大豆提取物经临床证明对乳房和子宫内膜安全*。


*对395名更年期女性进行的临床研究,每天服用70毫克大豆异黄酮,连续服用3年。研究发表于科学杂志Climateric 2010。食品安全由欧洲食品安全局确认:EFSA Journal 2015; 13 (10):4246 [342 pp]。

膳食补充剂.
仅限45岁以上的女性服用.

  • 每天早晚各服用1粒胶囊,随餐用一大杯水送服(250ml).
    如有需要,可将剂量增加至每天4粒胶囊(早晚各2粒).

注意事项

  • 不建议孕妇和哺乳期女性服用.
  • 不建议乳腺癌或有乳腺癌家族遗传史的人群服用.
  • 膳食补充剂不能替代平衡、多样的饮食以及健康的生活方式.
  • 勿超过每日建议用量.
  • 请置于儿童不能触及的地方.
  • 避免高温、阳光照射及潮湿环境.

Albert A, Altabre C, Baro F, Buendia E, Cabero A, Cancelo Mj et al. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology : a multicentric, open, prospective and non-randomized trial. Phytomedicine 2002;9:85-92.

Brzezinski A, Adlercreutz H, Shaoul R, Rosier A, Shmueli A, Tanos V et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4(2):89-94.

Chedraui P, San Miguel G, Schwager G. The effect of soy-derived isoflavones over hot flushes, menopausal symptoms and mood in climacteric women with increased body mass index. Gynecol Endocrinol 2011;27(5):307-13.

Cianci A, Cicero AF, Colacurci N, Matarazzo MG, De Leo V. Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. Gynecol Endocrinol 2012;28(9):699-702.

Crawford SL, Jackson EA, Churchill L, Lampe JW, Leung K, Ockene JK. Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial. Menopause 2013;20(9):936-45.

Franco OH, Chowdhury R, Troup J, Voortman T, Kunutsor S, Kavousi M et al. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. JAMA 2016;315(23):2554-63.

Hirose A, Terauchi M, Akiyoshi M, Owa Y, Kato K, Kubota T. Low-dose isoflavone aglycone alleviates psychological symptoms of menopause in Japanese women: a randomized, double-blind, placebo-controlled study. Arch Gynecol Obstet 2016;293(3):609-15.

Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas 2007;58(3):249-58.

Palacios S, Mares P, Pornel B, Chantre P. Endometrial safety assessment of a specific and standardized soy isoflavones extract (PHYTO SOYA®) in post-menopausal women. Menopause 2006;13(6):1009.

Palacios S, Pornel B, Vázquez F, Aubert L, Chantre P, Marès P. Long-term endometrial and breast safety of a specific, standardized soy extract. Climacteric 2010;13(4):368‑75.

Scambia G, Mango D, Signorile P, Angeli R, Palena C, Gallo D et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7(2):105-11.

Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL et al. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am J Clin Nutr 2011;93(2):356-67.

Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause 2012;19(7):776-90.

Tranche S, Brotons C, Pascual de la Pisa B, Macías R, Hevia E, Marzo-Castillejo M. Impact of a soy drink on climacteric symptoms: an open-label, crossover, randomized clinical trial. Gynecol Endocrinol 2016;32(6):477-82.

Upmalis D, Lobo R, Bradley L, Warren M, Cone F, Lamia C. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicentre, double-blind, randomized, placebo-controlled study. Menopause 2000;7(4):236-42.

Wasburn S, Burke Gl, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6(1):7-13.